Advanced search
Publication Cover
Expert Review of Vaccines Volume 21, 2022 - Issue 11
Submit an article Journal homepage
205
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States

Sophia Hatziantonioua Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, GreeceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5877-9091View further author information
ORCID Icon,
Cleo Anastassopouloub Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceORCID Iconhttps://orcid.org/0000-0001-7666-9198View further author information
ORCID Icon,
George Lazarosc First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, GreeceView further author information
,
Konstantinos Vasileioud Department of Pharmacy, School of Health Sciences, University of Patras, Patras, GreeceView further author information
,
Costas Tsioufisc First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, GreeceView further author information
&
Athanasios Tsakrisb Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceORCID Iconhttps://orcid.org/0000-0003-0656-4715View further author information
ORCID Icon
Pages 1691-1696 | Received 01 Nov 2021, Accepted 08 Jul 2022, Published online: 25 Jul 2022

References

  • Fauci AS. The story behind COVID-19 vaccines. Science. 2021;372(6538):109.
  • Ball P. The lightning-fast quest for COVID vaccines - and what it means for other diseases. Nature. 2021;589(7840):16–18.
  • Editorial. Messengers of hope. Nat Biotechnol. 2021;39(1):1.
  • European Medicines Agency. EudraVigilance-European database of suspected adverse drug reaction reports and European Centre for disease prevention and control, COVID-19 vaccine tracker. [cited 2021 Oct 8]. Available from: https://www.adrreports.eu
  • Vaccine Adverse Event Reporting System. 2021 [cited 2021 Oct 15]. Available from: https://vaers.hhs.gov/data.html.
  • Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021;39(29):3790–3793.
  • Lazaros G, Anastassopoulou C, Hatziantoniou S, et al., A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine. 2021;39(45):6585–6590.
  • Lazaros G, Klein AL, Hatziantoniou S, et al., The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine. 2021;39(35):4925–4927.
  • Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19:75–77.
  • Kreimeyer K, Menschik D, Winiecki S, et al. Probabilistic record linkage of structured and unstructured data to identify duplicate cases in spontaneous adverse event reporting systems. Drug Saf. 2017;40:571–582.
  • European Centre for Disease Prevention and Control. [cited 2021 Oct 8]. Available from: https://vaccinetracker.ecdc.europa.eu.
  • Ritchie H, Ortiz-Ospina E, Beltekian D, et al. Coronavirus Pandemic (COVID-19). 2020. [cited 2021 Oct 15]. Available from: https://ourworldindata.org/coronavirus
  • Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021;326(12):1210–1212.
  • Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331–340.
  • Authelin JR, Rodrigues MA, Tchessalov S, et al. Freezing of biologicals revisited: scale, stability, excipients, and degradation stresses. J Pharm Sci. 2019;109(1):44–61.
  • Crommelin DJA, Anchordoquy TJ, Volkin DB, et al. Addressing the cold reality of mRNA vaccine stability. J Pharm Sci. 2021;110(3):997–1001.
  • Shimabukuro TT, Nguyen M, Martin D, et al. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33:4398–4405.
  • Montano D. Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States. Front Public Health. 2022;(9):756633. doi:10.3389/fpubh.2021.756633.
  • Institute of Medicine (US) Committee to Study New Research on Vaccines, Stratton KR, Howe CJ, Johnston RB, editors; Research strategies for assessing adverse events associated with vaccines: a workshop summary. In: Case Reports And Passive Surveillance. Washington (DC): National Academies Press (US); 1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.